PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Canadian Center for Vaccinology, Dalhousie University, IWK Health, Nova Scotia Health, Halifax, Canada. Electronic address: scott.halperin@dal.ca.\', \'Canadian Center for Vaccinology, Dalhousie University, IWK Health, Nova Scotia Health, Halifax, Canada.\', \'Fundación Huésped, Buenos Aires, Argentina.\', \'Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'National Institute of Health, Islamabad, Pakistan.\', \'Universidad de la Frontera, Temuco, Chile.\', \'Federal State Budgetary Institution, Smorodintsev Research Institute of Influenza, St Petersburg, Russia.\', \'Medical School, Novosibirsk State University, Novosibirsk, Russia.\', \'Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.\', \'CanSino Biologics, Tianjin, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0140-6736(21)02753-710.1016/S0140-6736(21)02753-7
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34953526
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34953526>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34953526>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all